ÎÞÓÇÊÓƵ

Patients
Self Reflected by Greg Dunn

Working with patients in mind

We are developing new treatments for conditions like depression and alcohol use disorder, and we work closely with people from across the mental health ecosystem to push forward research, inform our clinical development and support clinical trial participants. 

We know that psychedelic-based treatments can bring about powerful experiences. That is why we are committed not just to innovation, but to listening, learning and acting on the insights of those with experience of living with mental health conditions and taking part in psychedelic clinical studies. Their perspectives inform everything we do, from how we design our studies to how we support participants before, during and after treatment. 

Clinical research guided by experience

We are working to develop effective, rapid-acting and convenient new treatment options for people living with difficult-to-treat mental health conditions. We are deeply grateful to the 250+ participants who have already contributed to our research via clinical trials. Their invol